Procter & Gamble gets approval for new Actonel dose (AP via Yahoo! Finance)

Consumer products company Procter & Gamble Co. said Thursday the Food and Drug Administration approved a once-a-month version of its osteoporosis drug Actonel.

This entry was posted on Thursday, April 24th, 2008 at 5:18 pm and is filed under Osteoporosis. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.